Impacts of a New Episode-Based Payment Scheme on Volume, Expenditures, and Efficiency in Public Hospitals: A Quasi-Experimental Interrupted Time-Series Study in Jinhua, China
Tao Zhang,Beiyin Lu,Zhongheng Yan,Xiaojun Huang,Wei Lu
DOI: https://doi.org/10.2147/RMHP.S376516
2022-09-06
Risk Management and Healthcare Policy
Abstract:Tao Zhang, 1 Beiyin Lu, 1 Zhongheng Yan, 2 Xiaojun Huang, 3 Wei Lu 3, 4 1 Department of Health Policy and Management, Hangzhou Normal University, Hangzhou, People's Republic of China; 2 Office of the Vice President, Central Hospital of Hainan Province Western, Haikou, People's Republic of China; 3 School of Management, Hainan Medical University, Haikou, People's Republic of China; 4 Department of Science and Education, Hainan Women and Children's Health Care Centre, Haikou, People's Republic of China Correspondence: Wei Lu, School of Management, Hainan Medical University, No. 3 Xueyuan Road, Longhua District, Haikou, 5711993, People's Republic of China, Tel +86 15971499800, Fax +8602767813016, Email Purpose: Based on the diagnosis-related groups payment, China developed an innovative episode-based payment scheme, called "payment method by disease types with point counting", to control health expenditures inflation. This study aimed to investigate the impacts of this new payment method on volume, expenditures, and efficiency in Chinese public hospitals. Methods: The study sample consisted of 7 tertiary hospitals and 14 secondary hospitals in Jinhua (intervention group) and 4 tertiary hospitals and 14 secondary hospitals in Taizhou (control group). Monthly data points were collected for each sampled hospital from June 2016 to June 2019 using a self-administered questionnaire with impact evaluation indicators. Controlled interrupted time-series analysis was employed to estimate the effect of the new payment method. Results: The significant slowing trends in inpatient expenditures per visit (tertiary hospitals: β 7 =− 123.16, p=0.042; secondary hospitals: β 7 =− 89.24, p=0.021) and out-of-pocket payments (tertiary hospitals: β 7 =− 4.18, p=0.027; secondary hospitals: β 7 =− 4.87, p=0.019) were observed after policy intervention. However, outpatient expenditures per visit in tertiary (β 7 =1.67, p=0.018) and secondary hospitals (β 7 =1.24, p=0.003) rose faster with the new payment method. Additionally, payment reform also caused an increase in the number of inpatient visits (β 7 =100.01, p=0.038) and reduced the length of stay (β 7 =− 0.10, p=0.036) in tertiary hospitals. Conclusion: The introduction of payment method by disease types with point counting causes the cost containment for inpatient care, whereas the increase in outpatient expenditures. The findings suggest this new payment scheme has the potential for rollout in other areas, but the cost-shifting from the inpatient to outpatient setting should be prevented. Keywords: episode-based payment, expenditures, public hospitals, controlled interrupted time series, China Rapid growth in health care expenditures in high-income and lower-middle-income countries has become a significant concern for policymakers and the public. 1 China is not exceptional. Total health expenditures in China increased from 1,9980.4 billion RMB in 2010 to 65,195.9 billion RMB in 2019 and are growing at a rate of more than 10% per year. 2 Soaring health expenditures threw a great challenge on China's health system. Fee-for-service (FFS) payment drives the rising medical expenditure by incentivizing overtreatment. 3 In recent years, the Chinese government has been determined to explore alternative payment approaches. Although several payment methods (eg, global budgets, capitation) have been adopted since the new reform of China's health system in 2009, one of the payment methods called diagnosis-related groups (DRGs) attracted widespread attention. Under the DRG-based payment system, hospitals are remunerated with a fixed predefined amount according to the characteristics and disease complexity of patients regardless of the actual costs that hospitals incur for treatments. 4,5 In comparison with FFS, DRG-based payment transfers the financial risk to healthcare providers and therefore encourages them to increase efficiency and avoid overtreatment. Some cities in China (eg, Beijing, Zhongshan) have already piloted a DRG-based payment ten years ago. 5,6 Concerning the effectiveness of this payment scheme, existing studies proved that it reduced health expenditures and out-of-pocket (OOP) payments. 6–8 However, some unintended consequences were reported as well. For example, hospitals provided inadequate services, discharged patients prematurely, and decreased the quality of care. 7,9 Moreover, previous studies also found unnecessary admissions, patient cream-skimming, and upcoding under the DRGs system. 8,10 To overcome these shortcomings, Jinhua, an -Abstract Truncated-
health care sciences & services,health policy & services